查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012288

數位乳房斷層合成市場：按組件、最終用戶、應用、技術和安裝數量分類 - 2026-2032 年全球預測

Digital Breast Tomosynthesis Market by Component, End User, Application, Technology, Installation - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

數位乳房斷層合成市場預計到 2025 年將達到 50.9 億美元，到 2026 年將成長到 58.1 億美元，到 2032 年將達到 137.7 億美元，年複合成長率為 15.27%。

主要市場統計數據
基準年 2025 50.9億美元
預計年份：2026年 58.1億美元
預測年份 2032 137.7億美元
複合年成長率 (%) 15.27%

這本以策略性和臨床為重點的數位乳房斷層合成入門指南系統地說明了診斷優勢、推廣應用的促進因素以及相關人員整合的必要性。

數位乳房斷層合成技術正迅速成為一項關鍵的影像技術，它正在革新乳癌篩檢途徑以及急診和門診的臨床工作流程。這項技術的應用使其融入不斷發展的臨床環境，其中3D容積成像克服了傳統2D乳房乳房X光攝影光攝影的局限性，提高了病灶的可見度，並降低了異質性乳房組織中的複查率。隨著醫療系統日益重視與早期發現和診斷準確性相關的品質指標，數位乳房斷層合成技術正變得越來越符合臨床需求和多學科診療模式。

技術、臨床和商業性的變革正在重新定義數位乳房斷層合成的格局，並重塑供應商和醫療保健提供者的策略。

數位乳房斷層合成領域正經歷著一場變革性的轉變，這場轉變正在重新定義臨床實踐、廠商競爭格局以及醫療保健系統的投資重點。其中一個關鍵變化是軟體主導增強技術的成熟，例如先進的重建技術和輔助放射科醫生解讀影像的人工智慧。這些技術正在將差異化競爭的重點從單純的硬體性能轉移到結合了採集、處理和決策支援功能的綜合成像解決方案。因此，廠商正在推行模組化產品策略，優先考慮軟體更新和雲端分析功能，以維持產品的長期臨床效用。

2025 年關稅變化如何推動整個數位乳房斷層合成生態系統的供應鏈重組、採購優先順序調整和策略定價調整。

2025年美國關稅的累積影響為數位乳房斷層合成領域的相關人員帶來了新的考量，涉及供應鏈管理、採購計劃和定價策略等方面。影響進口零件和子組件的關稅調整促使供應商即時進行重新評估，導致許多原始設備製造商 (OEM) 重新審視其採購慣例和緊急庫存。為此，採購團隊更加重視供應商多元化，並在多個司法管轄區選擇替代供應商以降低風險。這項轉變也加速了關於近岸外包和區域組裝的討論，以平衡成本、物流複雜性和前置作業時間容忍度。

透過對組件、最終用戶、應用、技術和安裝配置進行詳細的細分分析，揭示了買家多樣化的需求和供應商的策略。

關鍵的細分市場洞察揭示了組件架構、用戶環境、臨床應用、技術差異和安裝配置如何影響數位乳房斷層合成解決方案的需求模式和策略重點。基於組件，市場分析涵蓋硬體、服務和軟體三大支柱。這種三支柱結構意味著，競爭差異化越來越依賴捆綁式服務和軟體功能，這些功能能夠提供超越影像擷取的價值。因此，那些能夠將強大的硬體、可擴展的服務模式和持續的軟體改進相結合的機構，正在大規模醫院系統和集中式診斷網路中獲得越來越多的市場佔有率。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和部署重點正在推動針對每個地區量身定做的部署和籌資策略。

區域趨勢顯著影響數位乳房斷層合成影像技術的採用模式、報銷機制和優先順序。在美洲，私人保險公司和公共醫療項目並存，導致醫療保健系統內部的採購行為多種多樣。大規模綜合醫療網路和乳房專科中心通常優先考慮整合影像硬體、分析功能和服務支援的綜合解決方案。該地區的推廣計畫和行動篩檢舉措旨在解決服務不足地區醫療資源取得的差距，醫療服務提供者正在努力平衡促進篩選參與率和診斷後追蹤的營運模式與資本投入之間的關係。

影像供應商、軟體創新者和服務供應商之間的企業策略和競爭行為正在塑造數位乳房斷層合成領域的長期定位。

在企業層面，競爭格局正在形成，其特點是產品創新、策略夥伴關係以及對軟體和服務的日益重視。領先的影像設備製造商持續投資於檢測器改進和人體工學設計，同時強化其軟體藍圖，以提供更強大的重建功能和更最佳化的影像解讀工作流程。同時，專業軟體公司和人工智慧Start-Ups正在提供分析層，以提高病灶檢測、分流工作流程和報告的效率，從而促進硬體供應商和軟體開發商之間的策略合作和技術許可。

為供應商和醫療保健領導者提供以供應商觀點的可操作建議，以加強價值鏈、證據產生、互通性和基於價值的商業模式。

為了充分利用當前發展勢頭並應對宏觀經濟和政策方面的不利因素，行業領導者應制定一系列切實可行的優先事項，將商業性現實與臨床管理相結合。首先，各機構應實現供應鏈多元化，並對跨區域供應商進行認證，以降低關稅和物流風險，同時投資於庫存柔軟性和基於預測的採購，從而維持服務水準。其次，供應商需要優先考慮軟體的模組化和互通性，使成像系統能夠與企業電子健康記錄和影像歸檔系統無縫整合，從而促進在異構IT環境中的部署。

採用穩健的混合方法研究途徑，結合相關人員訪談、臨床文獻回顧、產品映射和檢驗，確保獲得嚴謹的見解。

本分析的調查方法結合了多種定性和定量方法，以確保研究的嚴謹性、透明度和對決策者的相關性。主要研究包括對臨床醫生、放射科負責人、採購負責人以及醫療機構和供應商的高級管理人員進行結構化訪談，從而獲得關於臨床需求、採購因素以及部署後服務期望的第一手觀點。此外，也透過系統性地回顧同儕審查的臨床文獻、技術白皮書、監管申報文件和醫療設備安全通告，對上述主要數據進行補充，以檢驗性能聲明、劑量考量和預期用途。

對決定數位乳房斷層合成技術未來實施和永續價值創造的臨床、營運和策略要求進行全面概述。

總之，數位乳房斷層合成技術體現了乳房攝影影像技術的成熟，兼顧了臨床效益、營運需求和不斷發展的商業模式。這項技術進步得益於影像擷取技術的改進、先進的軟體功能以及以服務為中心的經營模式的融合，從而實現了更精準的診斷和更有效率的工作流程。政策變化和價格趨勢雖然增加了供應鏈和採購計畫的複雜性，但也推動了採購和產品組合的策略重組與創新。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：數位乳房斷層合成市場：依組件分類

  • 硬體
  • 服務
  • 軟體

第9章：數位乳房斷層合成市場：依最終用戶分類

  • 學術研究機構
  • 乳癌診所
  • 診斷影像中心
  • 醫院

第10章：數位乳房斷層合成市場：依應用領域分類

  • 診斷
  • 篩檢

第11章：數位乳房斷層合成市場：依技術分類

  • 整合式辯證行為療法
  • 獨立辯證行為療法

第12章 數位乳房斷層合成市場：依安裝類型分類

  • 固定式
  • 移動單元

第13章：數位乳房斷層合成市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 數位乳房斷層合成市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：數位乳房斷層合成市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國數位乳房斷層合成市場

第17章：中國數位乳房斷層合成市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • DMS Imaging Co., Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • IMS Giotto SpA
  • Internazionale Medico Scientifica Srl
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Metaltronica SpA
  • PerkinElmer, Inc.
  • Planmed Oy
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Trivitron Healthcare Pvt. Ltd.
  • United Imaging Healthcare Co., Ltd.
  • Varex Imaging Corporation
  • Villa Sistemi Medicali SpA
Product Code: MRR-4312A385A3B3

The Digital Breast Tomosynthesis Market was valued at USD 5.09 billion in 2025 and is projected to grow to USD 5.81 billion in 2026, with a CAGR of 15.27%, reaching USD 13.77 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.09 billion
Estimated Year [2026] USD 5.81 billion
Forecast Year [2032] USD 13.77 billion
CAGR (%) 15.27%

A strategic and clinically focused introduction to digital breast tomosynthesis that frames diagnostic advantages, adoption drivers, and integration imperatives for stakeholders

Digital breast tomosynthesis has emerged as a pivotal imaging innovation that reshapes breast cancer detection pathways and clinical workflows across acute and outpatient settings. This introduction situates the technology within an evolving clinical landscape where three-dimensional volumetric imaging addresses limitations of conventional two-dimensional mammography by improving lesion conspicuity and reducing recall rates in heterogeneous breast tissue. As healthcare systems emphasize earlier detection and quality metrics tied to diagnostic accuracy, digital breast tomosynthesis increasingly aligns with clinical priorities and multidisciplinary care models.

Beyond imaging performance, adoption dynamics reflect a confluence of technological advancement, regulatory clearance trajectories, and payer policies that influence procurement and integration. Clinicians emphasize interoperability with picture archiving and communication systems, streamlined radiology reading workflows, and the ability to synthesize reconstructed views that preserve diagnostic confidence while managing radiation dose. Moreover, ongoing innovation in software, including image reconstruction algorithms and adjunct tools, supports more efficient reading and enhanced lesion characterization. In this context, the introduction clarifies how clinical value, operational feasibility, and strategic vendor capabilities jointly drive decisions among hospital systems, diagnostic centers, and specialty clinics.

Transformative technological, clinical, and commercial shifts reshaping the digital breast tomosynthesis landscape and reorienting vendor and provider strategies

The digital breast tomosynthesis landscape is undergoing transformative shifts that are redefining clinical practice, vendor competition, and health system investment priorities. A primary change is the maturation of software-driven enhancements, including advanced reconstruction techniques and artificial intelligence that augment radiologist interpretation. These technologies are shifting the locus of differentiation from hardware performance alone toward holistic imaging solutions that combine acquisition, processing, and decision-support capabilities. Consequently, vendors are pursuing modular product strategies that prioritize software updates and cloud-enabled analytics to sustain long-term clinical utility.

Concurrently, technological refinements in detector design, dose optimization, and multi-modality integration have expanded the use cases for three-dimensional mammography. Clinicians increasingly demand systems that provide synthesized two-dimensional reconstructions to preserve interpretive familiarity while capturing volumetric data. Moreover, mobility and site-of-care flexibility are gaining prominence; mobile units and compact installations enable outreach programs and decentralized screening initiatives. As reimbursement frameworks evolve to incentivize value-based diagnostics, providers must demonstrate outcome improvements and efficiency gains. This environment encourages closer collaboration across manufacturers, software developers, and service organizations to deliver end-to-end solutions that meet clinical, operational, and financial objectives.

How 2025 tariff shifts have driven supply chain reconfiguration, procurement re-prioritization, and strategic pricing adjustments across the digital breast tomosynthesis ecosystem

The cumulative impact of United States tariffs in 2025 has introduced new considerations across supply chain management, procurement planning, and pricing strategy for digital breast tomosynthesis stakeholders. Tariff adjustments affecting imported components and subassemblies prompted immediate supplier reassessments, leading many original equipment manufacturers to revisit sourcing practices and contingency inventories. In response, procurement teams increased emphasis on supplier diversification, qualifying alternative vendors across multiple jurisdictions to mitigate exposure. This shift also accelerated conversations about nearshoring and regional assembly to balance cost, logistical complexity, and lead-time resilience.

Operationally, manufacturers adjusted production planning to smooth cost volatility and maintain contractual commitments to healthcare providers. Some organizations absorbed incremental input costs to preserve market positioning, while others implemented selective price adjustments linked to premium features or bundled service agreements. The tariff environment also influenced capital procurement cycles within provider organizations; longer approval timelines and price uncertainty encouraged phased upgrades and a greater reliance on service contracts that extend asset life. Importantly, the policy context stimulated collaboration between industry associations and government relations teams to clarify tariff scope, pursue exemptions where applicable, and communicate implications to health system customers. Altogether, these developments underscore the need for dynamic supply chain strategies and transparent stakeholder communication to sustain adoption momentum under shifting trade conditions.

Deep segmentation insights across components, end users, applications, technologies, and installations that delineate differentiated buyer needs and vendor strategies

Key segmentation insights reveal how component architecture, user settings, clinical applications, technology variants, and installation formats shape demand patterns and strategic priorities for digital breast tomosynthesis solutions. Based on component, the market is studied across hardware, services, and software, and this tripartite structure means that competitive differentiation increasingly hinges on bundled service offerings and software-enabled functionality that extend value beyond imaging acquisition. Consequently, organizations that pair robust hardware with scalable service models and continuous software improvement gain traction with large hospital systems and centralized diagnostic networks.

Based on end user, the market is studied across academic and research institutes, breast cancer clinics, diagnostic imaging centers, and hospitals, and each setting imposes distinct requirements for workflow integration, throughput, and advanced diagnostic features. Academic and research institutes prioritize configurability and advanced research tools, while community hospitals emphasize cost-effective reliability and service coverage. Diagnostic imaging centers and breast cancer clinics often seek rapid turnaround, reimbursement-aligned workflows, and solutions that support screening volumes alongside diagnostic complexity. Based on application, the market is studied across diagnostic and screening, and these applications drive divergent specifications: screening emphasizes throughput, patient comfort, and dose management, whereas diagnostic applications demand higher-resolution reconstructions and adjunct modalities for problem solving.

Based on technology, the market is studied across integrated DBT and standalone DBT, and this distinction influences procurement choices; integrated platforms that combine tomosynthesis with other mammographic capabilities appeal to multi-service centers, while standalone DBT systems offer a targeted option for practices focused solely on advanced breast imaging. Based on installation, the market is studied across fixed unit and mobile unit, and mobility considerations shape programmatic outreach, especially for community screening initiatives and remote-area access programs. Taken together, these segmentation dimensions create a multi-layered buyer landscape where product architecture, service depth, and deployment flexibility determine commercial success.

Regional dynamics and deployment priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive tailored adoption and procurement strategies

Regional dynamics exert a meaningful influence on adoption patterns, reimbursement frameworks, and deployment priorities for digital breast tomosynthesis. In the Americas, health systems display heterogenous procurement behavior driven by a mix of private payors and public programs; large integrated delivery networks and specialized breast centers often prioritize comprehensive solutions that combine imaging hardware with analytics and service support. Within this region, outreach programs and mobile screening initiatives address access gaps in underserved communities, and providers balance capital investment with operational models that promote screening retention and diagnostic follow-up.

Across Europe, Middle East & Africa, regulatory harmonization, national screening guidelines, and public health initiatives shape uptake and procurement timelines. Public screening programs in several countries prioritize evidence-based technology that demonstrably reduces false recalls and improves diagnostic outcomes, which in turn influences tender specifications and vendor selection criteria. In diverse markets across the region, cost containment pressures coexist with investments in center-of-excellence imaging hubs. In Asia-Pacific, rapid infrastructure development and growing awareness of early detection benefits drive adoption in both metropolitan and regional centers. High-volume screening environments and a strong focus on integration with enterprise image management systems encourage vendors to emphasize throughput, automation, and localized service capabilities. Across all regions, cross-border partnerships and regional distributors play a pivotal role in facilitating regulatory submissions, training, and field maintenance programs.

Corporate strategies and competitive behaviors among imaging vendors, software innovators, and service providers that shape long-term positioning in digital breast tomosynthesis

Company-level dynamics reveal a competitive landscape characterized by product innovation, strategic partnerships, and an expanding emphasis on software and services. Leading imaging manufacturers continue to invest in detector improvements and ergonomic designs while bolstering software roadmaps that deliver reconstruction enhancements and interpretation workflows. At the same time, specialized software firms and AI startups contribute analytic layers that enhance lesion detection, triage workflows, and reporting efficiency, prompting strategic alliances and technology licensing arrangements between hardware vendors and software developers.

Service firms and managed equipment providers play a growing role in lifecycle management, offering flexible maintenance contracts, remanufacturing options, and uptime guarantees that matter to large healthcare customers. Competitive strategies increasingly combine traditional product differentiation with value-added services such as remote diagnostics, training programs, and performance benchmarking. Mergers, acquisitions, and minority investments remain instrumental tactics for incumbents seeking to accelerate entry into adjacent capabilities, including cloud-based image management, enterprise analytics, and advanced clinical decision support. Ultimately, successful companies align product roadmaps with clinical evidence generation, regulatory strategy, and payer engagement to create defensible positions and long-term customer relationships.

Actionable, provider-aligned recommendations for vendors and healthcare leaders to strengthen supply chains, evidence generation, interoperability, and value-based commercial models

To capitalize on current momentum and navigate macroeconomic and policy headwinds, industry leaders should pursue a set of actionable priorities that combine commercial pragmatism with clinical stewardship. First, organizations should diversify supply chains and qualify multi-regional suppliers to reduce tariff and logistics exposure, while simultaneously investing in inventory agility and forecast-driven procurement to maintain service levels. Second, vendors must prioritize software modularity and interoperability so that imaging systems can integrate seamlessly with enterprise electronic health records and picture archiving systems, thereby facilitating adoption across heterogeneous IT environments.

Third, investing in clinical evidence and real-world performance studies will strengthen reimbursement dialogues and support adoption in payer-driven markets; companies should partner with academic centers and large health systems to generate outcomes-oriented data that link tomosynthesis adoption to diagnostic accuracy and care pathway improvements. Fourth, expanding service offerings-such as managed maintenance, remote monitoring, and training programs-will create recurring revenue streams and increase customer retention. Fifth, stakeholders should explore flexible commercial models, including equipment-as-a-service arrangements and bundled imaging plus analytics subscriptions, to align with provider capital constraints and value-based payment incentives. Finally, leaders should prioritize clinician training and change management to ensure technologic advances translate into improved diagnostic workflows and patient outcomes, engaging radiologist champions to drive internal adoption and guideline updates.

Robust mixed-methods research approach combining stakeholder interviews, clinical literature review, product mapping, and triangulation to ensure rigorous insights

The research methodology underpinning this analysis combined multiple qualitative and quantitative approaches to ensure rigor, transparency, and relevance to decision-makers. Primary research included structured interviews with clinicians, radiology department leaders, procurement officers, and senior executives across provider and vendor organizations, providing first-hand perspectives on clinical requirements, procurement drivers, and post-deployment service expectations. These primary inputs were complemented by a systematic review of peer-reviewed clinical literature, technology whitepapers, regulatory filings, and device safety communications to validate performance claims, dose considerations, and intended use cases.

Secondary analysis involved mapping product portfolios, feature differentials, and service models across vendors to identify capability clusters and competitive vectors. Patent filings and conference proceedings added forward-looking insight into emerging capabilities and research priorities. Data triangulation was achieved by cross-referencing interview findings with clinical studies and product documentation, followed by iterative validation with independent clinical experts to reduce bias. The methodology also accounted for limitations such as uneven public reporting across vendors and regional regulatory variability, and it emphasized transparency about assumptions and the provenance of qualitative inputs to support reproducibility and confidence in the findings.

Concluding synthesis of clinical, operational, and strategic imperatives that determine future adoption and sustainable value creation in digital breast tomosynthesis

In conclusion, digital breast tomosynthesis represents a maturation of breast imaging that balances clinical benefits, operational imperatives, and evolving commercial models. The technology's trajectory is shaped by a convergence of improved image acquisition, advanced software capabilities, and service-centric business models that together enable more precise diagnosis and streamlined workflows. While policy shifts and tariff dynamics have introduced complexity into supply chains and procurement timelines, they have also catalyzed strategic realignment and innovation in sourcing and product configuration.

Looking ahead, stakeholders that invest in interoperability, clinical evidence generation, and flexible service models will be best positioned to translate technological advantages into sustained clinical adoption. Providers that align procurement with long-term maintenance and training commitments will preserve diagnostic continuity and maximize return on investment in patient outcomes. Vendors that emphasize modular software enhancement, partnerships with analytic developers, and transparent support networks will create differentiated offerings that resonate across diverse clinical settings. Overall, the digital breast tomosynthesis ecosystem is poised to deliver meaningful clinical impact provided that leaders act decisively to integrate technology, evidence, and operational readiness into coherent deployment strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Digital Breast Tomosynthesis Market, by Component

  • 8.1. Hardware
  • 8.2. Services
  • 8.3. Software

9. Digital Breast Tomosynthesis Market, by End User

  • 9.1. Academic And Research Institutes
  • 9.2. Breast Cancer Clinics
  • 9.3. Diagnostic Imaging Centers
  • 9.4. Hospitals

10. Digital Breast Tomosynthesis Market, by Application

  • 10.1. Diagnostic
  • 10.2. Screening

11. Digital Breast Tomosynthesis Market, by Technology

  • 11.1. Integrated Dbt
  • 11.2. Standalone Dbt

12. Digital Breast Tomosynthesis Market, by Installation

  • 12.1. Fixed Unit
  • 12.2. Mobile Unit

13. Digital Breast Tomosynthesis Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Digital Breast Tomosynthesis Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Digital Breast Tomosynthesis Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Digital Breast Tomosynthesis Market

17. China Digital Breast Tomosynthesis Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Analogic Corporation
  • 18.6. Canon Medical Systems Corporation
  • 18.7. Carestream Health, Inc.
  • 18.8. DMS Imaging Co., Ltd.
  • 18.9. Fujifilm Holdings Corporation
  • 18.10. GE HealthCare Technologies Inc.
  • 18.11. Hologic, Inc.
  • 18.12. IMS Giotto S.p.A.
  • 18.13. Internazionale Medico Scientifica S.r.l.
  • 18.14. Konica Minolta, Inc.
  • 18.15. Koninklijke Philips N.V.
  • 18.16. Metaltronica S.p.A.
  • 18.17. PerkinElmer, Inc.
  • 18.18. Planmed Oy
  • 18.19. Shimadzu Corporation
  • 18.20. Siemens Healthineers AG
  • 18.21. Trivitron Healthcare Pvt. Ltd.
  • 18.22. United Imaging Healthcare Co., Ltd.
  • 18.23. Varex Imaging Corporation
  • 18.24. Villa Sistemi Medicali S.p.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY BREAST CANCER CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY BREAST CANCER CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY BREAST CANCER CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INTEGRATED DBT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INTEGRATED DBT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INTEGRATED DBT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY STANDALONE DBT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY STANDALONE DBT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY STANDALONE DBT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY FIXED UNIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY FIXED UNIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY FIXED UNIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY MOBILE UNIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY MOBILE UNIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY MOBILE UNIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 102. GCC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 104. GCC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GCC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GCC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. GCC DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 120. G7 DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. G7 DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. G7 DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. G7 DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. G7 DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 126. NATO DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. NATO DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NATO DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NATO DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. NATO DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA DIGITAL BREAST TOMOSYNTHESIS MARKET SIZE, BY INSTALLATION, 2018-2032 (USD MILLION)